إعلان
إعلان

TIL

TIL logo

Instil Bio, Inc. Common Stock

7.20
USD
برعاية
-0.19
-2.58%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

7.21

+0.01
+0.08%

تقارير أرباح TIL

النسبة الإيجابية المفاجئة

TIL تفوق 7 من 19 آخر التقديرات.

37%

التقرير التالي

بيانات التقرير القادم
٠٢ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$2.56
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
+28.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
+40.66%

Instil Bio, Inc. Common Stock earnings per share and revenue

On ١٣ نوفمبر ٢٠٢٥, TIL reported earnings of -2.00 USD per share (EPS) for Q3 25, beating the estimate of -2.37 USD, resulting in a 15.50% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -7.20% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 المحللين forecast an EPS of -2.56 USD, with revenue projected to reach -- USD, implying an زيادة of 28.00% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Instil Bio, Inc. Common Stock reported EPS of -$2.00, beating estimates by 15.5%, and revenue of $0.00, 0% as expectations.
The stock price moved down -7.2%, changed from $14.99 before the earnings release to $13.91 the day after.
The next earning report is scheduled for ٠٢ مارس ٢٠٢٦.
Based on 5 المحللين, Instil Bio, Inc. Common Stock is expected to report EPS of -$2.56 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان